Resveratrol as a therapeutic agent for neurodegenerative diseases. - sprookjes - yvandenbroek - TriplyDB

Resveratrol as a therapeutic agent for neurodegenerative diseases.

Resveratrol as a therapeutic agent for neurodegenerative diseases.

http://www.wikidata.org/entity/Q37715832

about

Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms Exploring the Validity of Valproic Acid Animal Model of Autism Plant-derived neuroprotective agents in Parkinson's disease Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models Protective effects and mechanisms of sirtuins in the nervous system Structure of trans -Resveratrol in Complex with the Cardiac Regulatory Protein Troponin C Potential therapeutic effects of the MTOR inhibitors for preventing ageing and progeria-related disorders Mitochondrial function in hypoxic ischemic injury and influence of aging Resveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1 Sirt1 promotes axonogenesis by deacetylation of Akt and inactivation of GSK3 Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1 New delivery systems to improve the bioavailability of resveratrol.Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.Challenging oneself intermittently to improve health.Mutational analysis of the ability of resveratrol to inhibit amyloid formation by islet amyloid polypeptide: critical evaluation of the importance of aromatic-inhibitor and histidine-inhibitor interactions The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.Promise of resveratrol for easing status epilepticus and epilepsy.Drug development for Alzheimer's disease: recent progress Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system.Anti-oxidant polydatin (piceid) protects against substantia nigral motor degeneration in multiple rodent models of Parkinson's disease Implications of chronic daily anti-oxidant administration on the inflammatory response to intracortical microelectrodes.Systemic regulation of mammalian ageing and longevity by brain sirtuins.Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD.Critical review of resveratrol in xenobiotic-induced hepatotoxicity.Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3/IL-1β Axis in Microglia.trans-Resveratrol protects ischemic PC12 Cells by inhibiting the hypoxia associated transcription factors and increasing the levels of antioxidant defense enzymes.NAD+ and nicotinamide: sex differences in cerebral ischemia Accumulated hippocampal formaldehyde induces age-dependent memory decline.Aging-associated excess formaldehyde leads to spatial memory deficits.A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection.Effects of Resveratrol and trans-3,5,4'-Trimethoxystilbene on Glutamate-Induced Cytotoxicity, Heme Oxygenase-1, and Sirtuin 1 in HT22 Neuronal Cells The use of cortical spreading depression for studying the brain actions of antioxidants.Natural stilbenoids: distribution in the plant kingdom and chemotaxonomic interest in Vitaceae.Brain activation of SIRT1: role in neuropathology.mTOR: more targets of resveratrol?New perspectives on dietary-derived treatments and food safety-antinomy in a new era.Neuroprotective effects of resveratrol in Alzheimer disease pathology.

P2860

Q22251417-9100B432-9ECA-495F-AA5D-F58470437C7A Q26771764-E1A9222D-4B95-4090-97F0-67F36533CBE4 Q26795546-C0759BB0-4C76-4DFF-AE9C-A7C8512147CA Q26824390-7496DE71-1108-45C8-9380-673AC7EEB7BF Q26825585-09BE41AE-7B98-4152-A894-4E4E05B43623 Q27666558-427DA21B-3F52-4DE5-8D8E-77B4436538B2 Q28067037-8F283284-348C-45E8-BDC0-649ACB7FA9AA Q28396663-FB3AA875-CC74-4771-97A4-E5B7A7CA640F Q28488046-566E121C-314F-45E2-AE76-90165882D0DD Q28570544-CA629F93-2D7B-4E83-8719-2FF311401157 Q33580535-8FF5B824-A3BA-4FB5-A02B-DE5C33434875 Q34192059-73D0391A-69C7-4C6A-A3C7-0C70367A5765 Q34287719-77137A73-914C-4C6B-B273-BAD242952153 Q34710056-4990F36A-8D0A-416C-82A2-52E4A57A9FCA Q35027146-B02F3842-A1D1-4694-802D-57B1B8E165DE Q35036502-34F1BEBE-52B6-4E49-BE7B-FDE3D775597D Q35097960-59F74A53-6FFF-42AF-A1F4-C6A65CF49498 Q35545974-3A5EF6BE-B5EF-48DF-ADE5-FB5E1C55BC58 Q35566123-4047C440-DC9F-4272-8FBA-EDDA31B6E17D Q35838808-AF14C3A2-A13F-4AEA-BB24-ECE0A3A76990 Q35863280-EA50E3A8-B191-4585-B08B-38E350E00B8D Q35876167-C94CEC23-6BC2-4BE3-BCAD-6F0370FF4CEC Q35907645-723622FA-8713-4442-8D58-45347E7E532B Q35939194-2DEFFD50-43CE-43F7-8384-C5975E0CA8D7 Q36188186-69B5EDFD-75D6-40A0-9A3A-D21C5953D838 Q36454762-0E2B2EF8-71F3-4C41-A095-714538CC6AD7 Q36559325-18625D3B-921C-453C-A72D-0300C3FE824A Q36638599-7B5ECDFE-C1A9-4929-B594-2325384BE3FA Q36721687-83424D4C-88EA-445C-8CC8-A89FB823B6D2 Q36795198-D06861FE-7EE5-4EAF-B3BF-C83115B0B454 Q36829078-F6B73577-D92D-4A10-BDAA-578E007D4DC8 Q37012760-6FF4F0D1-4867-46E3-978D-A3EFBD22A302 Q37049075-77A04955-260F-4F89-98DD-A7C766CE1ED2 Q37224583-A4C64E83-C823-42E7-B71A-3B191C402D56 Q38009967-6D181AA5-999C-4D35-ABFA-28169089452B Q38046751-F66BF346-4A39-43EE-846E-7357B0778E96 Q38101493-BAD7B802-3281-4F60-A029-5AFE30C946AF Q38141246-E1ADC67E-8DF9-49BC-A9FB-34591EDCE8D4 Q38219163-8698CA47-3057-4A7C-9E98-2DEAD0DBC237 Q38259550-3E4A0C34-91F3-471D-9C58-6ED344365256

P2860

Resveratrol as a therapeutic agent for neurodegenerative diseases.

http://www.wikidata.org/entity/Q37715832

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@en

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@nl

type

label

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@en

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@nl

prefLabel

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@en

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@nl

P1433

Q37715832-BD954F6F-0E0E-4C09-9E12-3E9159FA5C52

P1476

Q37715832-5B79C587-F3B2-4A06-83EF-7F575E84569C

P2093

Q37715832-2D888144-D07F-4B3F-96F6-A6DD086DB2D5

Q37715832-5DE0269B-CF63-4547-AA8B-D73B7A5119A2

Q37715832-78E945A7-E315-4854-BEC2-B82A9FCB2B48

Q37715832-A8A269FD-12A4-4984-B03D-4A21DAD428AE

P2860

Q37715832-0889679D-838D-41F6-BE6B-14476616B938

Q37715832-0B43940B-5A50-4697-81B7-5AD6E6F07687

Q37715832-0DB36BAA-AE22-455C-A029-B36F9A19D29F

Q37715832-0DE30735-B4B9-4EF0-8145-12FD1B52111F

Q37715832-18E98E39-3C6D-40A5-8670-B27C91AD75A5

Q37715832-1A93BF4B-2B53-44C8-84C2-BA5539919078

Q37715832-1CDD047D-FD77-4B7B-AA37-90B4E8636223

Q37715832-21295760-A04A-4BFD-8265-D5001886CC82

Q37715832-229F9996-2925-403B-AF35-346626F758CE

Q37715832-24E975EA-2C04-458A-A8A0-8254099CB41E

P2888

Q37715832-680A8A4F-57E9-4D66-BF81-F047225ABD32

P304

Q37715832-666268AA-FAF3-4C09-81CF-DEF97A71C6FC

P31

Q37715832-9CF830F4-10D5-45AB-92BA-5C935A56D0A1

P356

Q37715832-0B983EDC-0BB7-4231-AFAF-60C91AFF9EB4

P433

Q37715832-D9C12644-B90B-4FF6-BA0E-7595F7DD1C81

P478

Q37715832-51A6DF6A-9F96-4F5C-BF53-E337D24369E2

P577

Q37715832-FECEC6D1-39EB-4E3F-9305-6E787C950A9A

P5875

Q37715832-E352A2DC-CC2E-4680-9AA4-11D140C0B734

P698

Q37715832-DBF2555B-89DF-4254-A22D-3D1148662B03

P921

Q37715832-87B83A98-EF53-4403-81F7-52A2793FCA28

P932

Q37715832-213782E6-4545-4B5D-8B45-E84E3096CBE5

P356

S12035-010-8111-Y

P1433

Molecular Neurobiology

P1476

Resveratrol as a therapeutic agent for neurodegenerative diseases.

@en

P2093

Agnes Simonyi

http://www.w3.org/2001/XMLSchema#string

Albert Y Sun

http://www.w3.org/2001/XMLSchema#string

Grace Y Sun

http://www.w3.org/2001/XMLSchema#string

Qun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Resveratrol improves health and survival of mice on a high-calorie diet

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

Deciphering the genetic basis of Alzheimer's disease

Small molecules that regulate lifespan: evidence for xenohormesis

SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis

Therapeutic potential of resveratrol: the in vivo evidence

Sirtuin activators mimic caloric restriction and delay ageing in metazoans

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

The free radical theory of aging matures

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders

P2888

s12035-010-8111-y

P304

375-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12035-010-8111-Y

http://www.w3.org/2001/XMLSchema#string

P433

2-3

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42373265

http://www.w3.org/2001/XMLSchema#string

P698

20306310

http://www.w3.org/2001/XMLSchema#string

P921

neurodegeneration

P932

3076208

http://www.w3.org/2001/XMLSchema#string